Software Healthcare Sector

Fortis Frontier

Market Cap: UK£2.7m

Develops, distributes, and commercializes at-home healthcare and wellness tests in the United Kingdom.

StageZero Life Sciences

Market Cap: CA$4.9m

A vertically integrated healthcare company, develops and commercializes proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications in North America and Western Europe.

BiomX

Market Cap: US$3.6m

A holding company, focuses on defense, security, and critical infrastructure technologies.

Alpha Compute

Market Cap: US$3.6m

A technology company, engages in the acquisition, deployment, and leasing of high-performance graphics processing units in data center facilities to power artificial intelligence in North America and Europe.

Calidi Biotherapeutics

Market Cap: US$3.6m

A biotechnology company, develops targeted therapies to deliver genetic medicines to distal sites of disease.

Cann Group

Market Cap: AU$5.0m

Engages in the breeding, cultivation, manufacture, and sale of medicinal cannabis in Australia and Europe.

Universe Pharmaceuticals

Market Cap: US$3.5m

Through its subsidiaries, engages in the manufacturing, marketing, distribution, and sales of traditional Chinese medicine derivative products in China.

Genetic Technologies

Market Cap: AU$5.7m

A molecular diagnostics company, engages in the provision of predictive genetic testing and risk assessment tools to help physicians manage people’s health in the America, Canada, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.

Rakovina Therapeutics

Market Cap: CA$4.8m

A biopharmaceutical research company, engages in the research and development of cancer treatments that target DNA-damage response systems.

LianMedical

Market Cap: US$3.4m

LianBio, operates as a biotechnology company in China and other Asian countries.

Visionflex Group

Market Cap: AU$4.8m

Together its subsidiaries, engages in the provision of healthcare, telehealth, and remote diagnostic solutions in Australia.

CTT Pharmaceutical Holdings

Market Cap: US$3.3m

Engages in the development of oral drug delivery systems for pain management and treatment.

Galmed Pharmaceuticals

Market Cap: US$3.3m

A biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases and related indications.

Herbal Dispatch

Market Cap: CA$4.6m

Engages in the sale of cannabis and cannabis related products in Canada and internationally.

Curis

Market Cap: US$3.3m

A biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States.

Genprex

Market Cap: US$3.3m

A clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes.

HITIQ

Market Cap: AU$4.5m

Develops and commercializes concussion management technology in Oceania.

Physiomics

Market Cap: UK£2.3m

Provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland.

Eastgate Biotech

Market Cap: US$3.2m

A development stage company, develops novel formulations of natural compounds and pharmaceutical products.

NewGenIvf Group

Market Cap: US$3.2m

An investment holding company, provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, Hong Kong, and Kyrgyzstan.

Artelo Biosciences

Market Cap: US$3.2m

A clinical stage biopharmaceutical company, develops and commercializes therapeutics that target lipid-signaling pathways in the United States.

Innovotech

Market Cap: CA$4.4m

Provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally.

Restart Life Sciences

Market Cap: CA$4.4m

Through its subsidiaries, operates as a biotechnology company in Canada.

bioAffinity Technologies

Market Cap: US$3.1m

Engages in developing non-invasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States.

REMSleep Holdings

Market Cap: US$3.1m

Focuses on the development and distribution of products to help people affected by sleep apnea worldwide.

Rafarma Pharmaceuticals

Market Cap: US$3.1m

A multi-product pharmaceutical company, produces and sells drugs, generic antibiotics, and specialty pharmaceuticals in Russia.

Futura Medical

Market Cap: UK£2.3m

Research, develops, and commercializes pharmaceutical and healthcare products for sexual health.

PRF Technologies

Market Cap: US$3.1m

A specialty pharmaceutical company, focuses on reformulation of established therapeutics in Israel.

LIR Life Sciences

Market Cap: CA$4.2m

Operates as biopharmaceutical company that develops transdermal delivery system for obesity and metabolic disorders.

TALi Digital

Market Cap: AU$4.2m

A digital health company, delivers diagnostic and therapeutic solutions to enhance attention cognitive function in Australia, New Zealand, and internationally.

Catheter Precision

Market Cap: US$3.0m

Designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States and Europe.

BSF Enterprise

Market Cap: UK£2.2m

Develops and commercializes cell-based tissue engineering solutions in the United Kingdom and Hong Kong.

Meridian Holdings

Market Cap: US$3.0m

Through its subsidiaries, provides healthcare management and information system solutions in the United States.

Enlitic

Market Cap: AU$4.2m

Operates in the healthcare sector in the United States, Europe, and Japan.

Invion

Market Cap: AU$4.1m

A clinical-stage life sciences company, researches and develops Photosoft technology for the treatment of cancers, atherosclerosis, and infectious diseases in Australia.

Argent BioPharma

Market Cap: AU$4.1m

A clinical-stage biopharmaceutical company, develops nano-engineered therapeutics that reset the balance between the nervous and immune systems in Malta, Slovenia, Australia, and internationally.